Bioventures Investors
Venture capitalWestborough · Seed–Growth · 16 people tracked
Also known as BIOVENTURES II MANAGEMENT CORPORATION
Find your way into Bioventures Investors
Sign up to see every warm intro you have to Bioventures Investors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bioventures Investors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BioVentures Investors focuses exclusively on the MedTech sector, backing emerging and growth-stage companies developing innovative medical technologies. The firm targets opportunities that deliver meaningful innovation benefiting patients, providers, and payers, help combat rising healthcare costs, and are attractive to potential acquirers. Leveraging deep industry experience across scientific, clinical, regulatory, policy, operating, and financial disciplines, the team plays an active role throughout the investment cycle—providing capital, guidance, and advice to develop companies and drive successful exits. Its aim is to advance better medical care while producing attractive financial returns for investors.
Source: firm website, verified Sep 29, 2026.
Team · 16 people
from the firm's website & curated & public directoriesWhat they invest in
from 8 of 10 portfolio companiesHealthtech ×6Medical Devices ×5Digital Health ×4Biotech ×3AI & Machine Learning ×2Deep Tech ×1Hardware ×1IoT ×1
HQs:United States×8
Investments · 10 tracked
founders shown can be your intro pathBy year:2023 · 12022 · 12020 · 12014 · 14 dated
BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms.
AI & Machine LearningBiotechDigital HealthMedical DevicesHouston, US
Steve Wallace(Chief Operating Officer, Global Supply Chain Management)inDonna J. Edmonds(CEO)inJames V. Snider(Chief Technology Officer / Advisor)Tim Van Meter(Chief Scientific Officer)Richard Noel(Chief Product and Commercial Officer)inRobert Sledd(Director)
Co-investorsAmbit Health VenturesGenoa VenturesVTC VenturesGENERAL INCEPTION
CoNextions Medical develops implantable devices for orthopaedic soft tissue repair, including systems for tendon repair and soft tissue-to-bone fixation intended for use by surgeons.
HealthtechMedical DevicesSalt Lake City, US
Erik N. Kubiak(Co-Founder | Chairman of the Medical Advisory Board | Director)Richard J Linder(Mr. Linder is President, CEO and a director of the Issuer.)inBrian Woolf(Executive Officer)Dan Gruppo(President and Chief Executive Officer)inDuraid Jwayyed(Chief Financial Officer)inAttila Poka(Chief Medical Officer)
Co-investorsKickstart
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)inAnthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Co-investorsAPERTURE Venture PartnersJumpstart VenturesLumira VenturesOSF VenturesSeroba Life SciencesSV Health Investors+1 more
Optivio is developing a biofeedback-based SaaS platform, preparing for launch with its first customers.
AI & Machine LearningDigital HealthHealthtechMental HealthSaaS
Jonathan P. Gertler(Chairman and Co-Founder)inChristine Magyar(Chief Financial & Administrative Officer)
SonoMotion develops ultrasound-based medical devices for treating kidney stones, working with urologists and clinical partners.
Deep TechHealthtechMedical DevicesSan Mateo, US
Oren Levy(Chief Executive Officer, Co-Founder)inPaul Douglas Corl(Executive Officer)Doug Corl(Chief Technology Officer)Michael Bailey(Executive Officer, Director)Barbrina Dunmire(Director)
Unified Information Devices (UID) develops RFID solutions—including implantable and external microchips, readers, home cage monitoring systems, and custom software—for identifying and tracking laboratory research animals and lab items.
BiotechHardwareIoTLake Villa, US
Verax Biomedical develops rapid bacterial contamination detection tests for blood products and tissues intended for transfusion and transplantation.
BiotechDigital HealthHealthtechMedical DevicesMarlborough, US
JOE R. SANDERS(Executive Officer, Director)inYLI REMO VALLEJO(Executive Officer)inR. SCOTT MCKENZIE, SR.(Executive Officer)inNANCY A. HORNBAKER(Executive Officer)inPAUL RAGUSA(Executive Officer)in
BoardMARC GOLDBERG(Director)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
3DBiopsyBiofeedback DesignCareSignal
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Bioventures Investors made?
- Bioventures Investors has 10 tracked investments.
- What stage does Bioventures Investors invest at?
- Bioventures Investors invests at the Seed, Series A, Growth stages.
- What is Bioventures Investors's typical check size?
- Bioventures Investors typically writes checks of $15M – $100M.
- What sectors does Bioventures Investors focus on?
- Bioventures Investors focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Bioventures Investors located?
- Bioventures Investors is headquartered in Westborough, US.
- Does Bioventures Investors lead rounds?
- Yes, Bioventures Investors leads investment rounds.
- Who does Bioventures Investors co-invest with?
- Bioventures Investors most often shares deals with OSF Ventures, Bold Capital Partners, Genoa Ventures, among 15 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.










































.jpeg)
